期刊文献+

X连锁凋亡抑制蛋白和生存素在鼻腔鼻窦内翻性乳头状瘤中的表达及意义 被引量:4

Expression and its significance of XIAP and survivin in sinonasal inverted papilloma
下载PDF
导出
摘要 目的研究X连锁凋亡抑制蛋白(X-linked inhibitor of apoptosis protein,XIAP)、生存素(Survivin)在鼻腔鼻窦内翻性乳头状瘤(nasal inverted papilloma,NIP)发生、发展及恶变中的表达情况。方法 NIP 45例,正常鼻腔黏膜(nasal cavity mucosae,NM)10例,NIP组按不同病理分级分为三组,即无不典型增生组25例,伴有不典型增生组11例,恶变组9例,通过免疫组化SP法进行XIAP和Survivin检测。结果 XIAP、Survivin在NM、NIP组间的表达具有统计学意义(UXIAP=76.000,PXIAP<0.001;Usurvivin=150.000,Psurvivin=0.036),在NIP不同病理分级中,组织分化程度越低,XIAP与Survivin阳性表达强度越高,无不典型增生组及恶变组间的表达具有统计学意义。XIAP与Survivin表达正相关(rs=0.375,P=0.011)。结论XIAP和Survivin与NIP的发病及恶变有关。 OBJECTIVE To explore the expression of X-linked inhibitor of apoptosis protein (XIAP) and survivin in sinonasal inverted papilloma (NIP) . METHODS Immunohistochemical method was used to detect the expression of XIAP and survivin in 45 specimens of NIP, 10 specimens of nasal cavity mucosa (NM) . There were 25 specimens of NIP without dysplasia, 11 with dysplasia, and 9 with canceration to squamous cell carcinoma (SCC) . RESULTS The positive expression of XIAP and survivin had significantly differences between the NM and NIP group (UxAP=76.000, PxAP 〈 0.001; Usurvivin=150.000, Psorivn=0.036) . The expression between NIP without dysplasia and SCC had significantly differences. The expression of XlAP positively correlated with the expression of survivin (rs=0.375, P=0.011) . CONCLUSION XlAP and survivin were associated with the growth and carcinogenesis of NIP.
出处 《中国耳鼻咽喉头颈外科》 CSCD 2013年第5期255-257,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 乳头状瘤 内翻 鼻腔 鼻窦 X连锁凋亡抑制蛋白质 免疫组织化学 生存素 Papilloma, Inverted Nasal Cavity Paranasal Sinuses X-Linked Inhibitor of ApoptosisProtein Immunohistochemistry Survivin
  • 相关文献

参考文献7

  • 1Lesperance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope, 1995, 105: 178-183.
  • 2Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating lAP inhibition. Cell, 2000, 102: 33-42.
  • 3Wright ME, Han DK, Hockenbery DM. Caspase-3 and mammatian cells. FEBS Lett, 2000, 481 : 13- 14.
  • 4Poetker DM, Sandier AD, Scott DL, et al. Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol, 2002, 111 : 957-961.
  • 5李晓明,马秀茹,路秀英,崔丽萍,董文荣.凋亡抑制蛋白XIAP在喉鳞状细胞癌中的表达及其临床病理学意义[J].临床耳鼻咽喉头颈外科杂志,2007,21(21):973-975. 被引量:11
  • 6Rohayem J, Diestelkoeer P, Weigle B, et al. Antibody response to the tumor-associated inhibitor of apoptosis protein Survivin in cancer patients. Cancer Res, 2010: 1815- 1817.
  • 7胡光维.Survivin基因的表达及其与鼻肿瘤细胞增殖的关系[J].中国初级卫生保健,2011,25(9):94-95. 被引量:1

二级参考文献18

  • 1Meng H,Lu C,Mabuchi H,et al.Prognostic significance and different properties of Survivin splicing variants in gastric cancer[J].Cancer Lett,2010,216(2):147-155.
  • 2Kawasaki H,Toyoda M,Shinohaka H,et at.Expression of Survivin correlates with apoptosis,proliferation,and an giogenesis during human eolortectal tumorigenesis[J].Cancer,2009 (91):2026-2032.
  • 3Taubert H,Kalpler M,Bache M,et at.Elevated Expression of Surviving Splice Variants Predicts a Poor Outcome for Soft Tissue Sarcomas Patients[J].Oncogene,2010,24 (33):5258-5261.
  • 4Asanuma KTSuji N,Endoh T,et al.Survivin enhances fas ligand expression Via up Regulation of Specificity Protein 1 mediated gene transcription in colon cancer cells[J].Immunol,2009,172(6):3922-3929.
  • 5Ryan B,O Donovan N,Browne B,et at.Expression of Survivin and its splice variants Surviving-2B and Survivin deltaEx3 in breast cancer[J].Br J Cancer,2010,92(1):120-124.
  • 6Mahotka C,Krieg T,Krieg A,et al.Distinct in vivo expression patterns of Survivin splice variants in renal cell carcinomas[J],Int J cancer,2010,100(1):30-36.
  • 7Takashima H,Nakajima T,Moriguchi M,et at.In vivo expression patterns of Survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma[J].Laverint,2011,25(1):77-84.
  • 8Rohayem J,Diestelkoeer P,Weigle B,et al.Antiboly response to the tumor-associated inhibitor of apoptosis protein Survivin in cancer patients[J].Cancer Res,2010(60):1815-1817.
  • 9Fujie Y,Yamamoto H,Ngan CY,et al.Oxaliplatin,a potent inhibitor of surviving,enhances paclit axel induced apoptosis and mitotic catastrophe in colon cancer cells[J].Jpn J Clin Oncol,2009,35(8):453-463.
  • 10Zaffaroni N,Pennati M,Daidone MG.Survivin as a target for new anticancer interventions[J].Cell Mol Med,2010,9(2):360-372.

共引文献10

同被引文献15

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部